Final hours! Save up to 55% OFF InvestingProCLAIM SALE

European Stock Futures Higher; Ukraine/Russia Peace Talks in Focus

Published 29/03/2022, 07:28
© Reuters
EUR/USD
-
XAU/USD
-
DE30
-
GC
-
LCO
-
UK100
-
CL
-
F40
-
SNY
-

By Peter Nurse 

Investing.com - European stock markets are expected to open marginally higher Tuesday ahead of the start of another round of peace talks between Ukraine and Russia in Turkey this week. 

At 2 AM ET (0600 GMT), the DAX futures contract in Germany traded 0.4% higher, CAC 40 futures in France climbed 1.2% and the FTSE 100 futures contract in the U.K. rose 0.6%.

Ukrainian and Russian negotiators are set later Tuesday to meet in Turkey for face-to-face talks, the first direct talks between the two sides in more than two weeks.

However, despite the stock market gains, there appears little hope of a breakthrough, with Kyiv seeking a ceasefire without compromising on territory or sovereignty while Russia continues to make territorial demands, including Crimea, which Moscow seized and annexed in 2014, and some eastern territories.

Ahead of the talks, Ukrainian President Volodymyr Zelensky on Monday urged Western nations to toughen sanctions quickly against Russia, including an oil embargo, something a number of European countries have been reluctant to impose given their reliance on Russian energy supplies.

U.S. and German government officials are set to meet later this week with energy industry executives to discuss ways to boost alternative supplies for Germany, the Eurozone’s largest economy which has been reliant on Russian oil and gas.

Looking at the European economic data slate, the GfK German consumer climate index fell to -15.5 for April, down from a revised -8.5 the previous month, as the war in Ukraine and rising commodity prices weigh on sentiment.

Later in the session, the Bank of England is set to publish its latest Quarterly Bulletin, which will be studied carefully as the U.K. central bank continues to increase interest rates.

In corporate news, Sanofi (PA:SASY) (NASDAQ:SNY) will be in the spotlight after the French healthcare group raised its peak sales target for eczema-treatment product Dupixent to more than 13 billion euros ($14.3 billion).

Oil prices retreated Tuesday, continuing the previous session’s weakness on fears that a surge in Covid-19 cases in China will hit demand from the world’s top crude importer and ahead of the Ukraine/Russia peace talks.

The city of Shanghai, China’s financial hub, remains under a two-stage, nine-day lockdown to curb rising numbers of Covid cases.

Sanctions imposed on Russia after it invaded Ukraine have disrupted oil supplies from the world’s second largest crude exporter, sending prices to 14-year highs earlier this month. 

By 2 AM ET, U.S. crude futures traded 0.6% lower at $105.36 a barrel, while the Brent contract fell 0.5% to $108.98. Both benchmark contracts lost around 7% on Monday.

Additionally, gold futures fell 0.9% to $1,922.85/oz, while EUR/USD traded 0.1% higher at 1.0987.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.